Yingzhe Li

Yingzhe (Angela) Li is a seasoned professional in therapeutic research with extensive experience in CAR-T and TCR-T therapy development. Currently serving as Senior Director of Therapeutic Research at BlueSphere Bio since March 2024, Yingzhe has previously held senior roles at Landmark Bio and Mnemo Therapeutics, where innovative therapies for solid and liquid tumors were developed and laboratory expansions were facilitated. At Legend Biotech, Yingzhe advanced CAR-T and CAR-NK projects and successfully built teams to drive these therapies from inception to clinical readiness. With a foundational career at Johnson & Johnson and Merck, Yingzhe contributed to groundbreaking therapeutic platforms and received several Innovation Leadership Awards. Academic training includes a Research Fellowship at Duke University.